Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease

Curēus
Linda M ShecterleJohn A St Cyr

Abstract

Cardiovascular disease still remains the leading cause of deaths worldwide. Atherosclerosis, the most common type of cardiovascular disease, has continued to progress due to many factors, genetics, and lifestyles. All cells require adequate adenosine triphosphate (ATP) levels to maintain their integrity and function. Myocardial ischemia commonly found in atherosclerosis can produce lower levels of ATP, which affects not only cellular energy, but also alters normal function. D-ribose, a naturally occurring pentose carbohydrate, has been shown to increase cellular energy levels and improve function following ischemia in pre-clinical studies and have demonstrated potential benefits in clinical evaluations. This review paper presents an overview of ischemic cardiovascular disease and the potential role that D-ribose could play in improving myocardial energy levels and function in the area of ischemic cardiovascular diseases.

Methods Mentioned

BETA
nuclear magnetic resonance
GTPase
coronary artery bypass

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Recent Patents on Cardiovascular Drug Discovery
Linda M ShecterleJohn A St Cyr
The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy
Robert H Brookman, John A St Cyr
Progress in Cardiovascular Nursing
Susan WagnerJohn A St Cyr
Advances in Bioscience and Clinical Medicine
Diane E MahoneyJanet D Pierce
© 2022 Meta ULC. All rights reserved